A Randomised Open-Label Comparative Clinical Study to Evaluate the Efficacy of ‘Nasya Karma with Upanaha’ and ‘Nasya Karma with Jambira Pinda Swedana’ in the Management of Cervical Spondylosis
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
- 试验地点
- 1
研究概览
简要总结
Cervical spondylosis is a common degenerative condition of the neck that causes neck pain, stiffness, restricted movements, and sometimes radiating pain to the arms. It commonly affects adults due to aging, poor posture, prolonged computer or mobile use, and sedentary lifestyle. Conventional treatment mainly provides symptomatic relief and may not be suitable for long-term use in all patients.
Ayurveda describes a similar condition as Manyastambha, which is managed using therapies like Nasya (nasal administration of medicated oil) and local fomentation procedures. Nasya is considered an important therapy for diseases of the head and neck, while external heat therapies help in reducing pain, stiffness, and improving mobility.
The purpose of this study is to compare the effectiveness of two Ayurvedic treatment approaches—Nasya therapy combined with Upanaha Swedana and Nasya therapy combined with Jambira Pinda Swedana—in reducing neck pain, improving neck function, and decreasing disability in patients with cervical spondylosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of age group 18-65 yrs of either gender.
- •2.Patients with any 2 or more Clinical features of cervical spondylosis, like: a.Chronic or recurrent neck pain b.Neck stiffness c.Decreased Range of Motion d.Headache e.Radiating pain 3.Patients fit for Nasya Karma and localized Swedana karma over Neck region.
- •4.MRI evidence of degenerative changes in the cervical spine, including any of the following: Disc degeneration, Disc bulge or protrusion, Disc herniation.
排除标准
- •1.Patients who are contraindicated for ShiroVirechana Nasya such as Pregnant women and lactating mothers, chronic rhinitis, etc.
- •2.Patients with renal or hepatic impairment (Sr. creatinine greater than 1.8 mgdl, SGOT and SGPT greater than THREE times of upper limit.
- •3.Patient having history of cervical instability, cord compression, central pain syndrome, cervical myelopathy, radiculopathy, compressive myelopathy, and muscle wasting, 4.Patients with comorbid conditions such as Hypertension (systolic greater than 160 mm Hg and diastolic greater than 100 mm Hg despite antihypertensive medications) and Diabetes Mellitus (having HbA1c greater than 7 percentage with or without oral hypoglycaemic medication).
- •5.Any medical red flag i.e. Spinal tumour, fracture, metabolic diseases, RA, spinal infection etc.
- •6.Patients requiring emergency treatment.
研究者
Akash Goel
Ayurvedic and Unani Tibbia College and Hospital